We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





The IFCC Launches Online Resource for COVID-19 Diagnostics

By LabMedica International staff writers
Posted on 28 Apr 2020
The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the umbrella organization encompassing national societies in the field in nearly 100 countries around the world, established an online resource providing key information on laboratory guidelines, biosafety, and other important matters to assist clinical laboratories as they face the challenges posed by the COVID-19 outbreak. More...
The web resource is constantly updated with the most recent information.

Headquartered in Milan, Italy, the global mission of the IFCC includes:
• Setting worldwide standards in collaboration with other international organizations;
• Supporting national members through scientific and educational initiatives;
• Organizing a series of congresses, conferences and meetings to serve as forums for specialists to interface and exchange findings.

Related Links:
IFCC Information Guide on COVID-19


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.